Evaluation of Orthopedic Knee Measurement Using Lunar iDXA
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01348958|
Recruitment Status : Completed
First Posted : May 6, 2011
Last Update Posted : June 22, 2017
|Condition or disease||Intervention/treatment||Phase|
|Hemi Knee Arthroplasty Patello-femoral Osteoarthritis||Device: iDXA knee software||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||36 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of Orthopedic Knee Measurement Using Lunar iDXA|
|Study Start Date :||July 2011|
|Actual Primary Completion Date :||September 2011|
|Actual Study Completion Date :||September 2011|
Experimental: Post-operative knee replacement
Subjects that have had a hemi knee replacement of one knee at least 8 weeks ago had the post-operative knee scanned using the orthopedic hip application and the Lunar orthopedic knee application.
Device: iDXA knee software
Following surgery, subjects who have undergone knee arthroplasty will have the knee that has undergone arthroplasty (post-operative) scanned at least 8 weeks after surgery.
During one visit, each subject will have the post-operative knee scanned 1 time using Lunar orthopedic application, and 3 times with the subject repositioned between scans using the Lunar orthopedic knee application (total of 4 scans). Lunar iDXA measurement procedures will be done
- Efficacy of Lunar orthopedic knee software. [ Time Frame: 5 months from starting study. ]This study will compare the bone density and bone mass measurements acquired with Lunar orthopedic knee software and for the same scans acquired with Lunar orthopedic software. A determination of precision of bone measurements acquired and analyzed with Lunar orthopedic knee software.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01348958
|CGM Research Trust - Princess Margaret Hospital|
|Cashmere, Christchurch, New Zealand, 8022|
|Principal Investigator:||Nigel Gilchrist, M.D.||CGM Reseach Trust - Princess Margaret Hospital|